Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 12

Results For "Bengaluru"

187 News Found

Stelis Biopharma’s flagship facility receives EIR from USFDA
Drug Approval | January 19, 2023

Stelis Biopharma’s flagship facility receives EIR from USFDA

The company is excited about the strategic progress that the company has made so far and are confident of delivering better business outcomes


Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences
News | January 10, 2023

Vidita Vaidya awarded Infosys Prize 2022 in Life Sciences

In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual


Indira IVF forays into diagnostic business with ‘Indira Pathlabs’
News | December 21, 2022

Indira IVF forays into diagnostic business with ‘Indira Pathlabs’

Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients


Strides receives USFDA approval for Potassium Chloride Oral Solution
Drug Approval | November 19, 2022

Strides receives USFDA approval for Potassium Chloride Oral Solution

The approval further strengthens the Potassium Chloride franchise for the company.


Strand Life Sciences launches ‘Strand Genomic Wellness’
Biotech | November 18, 2022

Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand’s new offering will help people better understand and manage diseases through genomic sequencing


NHA organises workshop to accelerate adoption of ABDM
Policy | November 01, 2022

NHA organises workshop to accelerate adoption of ABDM

The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage


Biocon Foundation receives Mahatma Award 2022
News | October 09, 2022

Biocon Foundation receives Mahatma Award 2022

The award was presented to Biocon Foundation as a mark of recognition of various projects undertaken during the year for reducing the environmental impact on cities


US FDA issues 17 observations for Biocon Biologics sites
News | September 01, 2022

US FDA issues 17 observations for Biocon Biologics sites

The observations primarily relate to the need for improving strategies for microbial control, enhancing quality oversight, augmenting the use of software applications & computerized tools


Stelis Biopharma’s flagship facility receives EIR from USFDA
Drug Approval | September 01, 2022

Stelis Biopharma’s flagship facility receives EIR from USFDA

The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise